Target Name: MT1XP1
NCBI ID: G645652
Review Report on MT1XP1 Target / Biomarker Content of Review Report on MT1XP1 Target / Biomarker
MT1XP1
Other Name(s): Metallothionein 1X pseudogene 1 | metallothionein 1X pseudogene 1 | MTL1

MT1XP1: A Potential Drug Target and Biomarker

MT1XP1, also known as Metallothionein 1X pseudogene 1, is a gene that has been identified as a potential drug target or biomarker for several diseases. MT1XP1 is a member of the metal transmembrane protein family, which includes several proteins that play a crucial role in the regulation of metal ions and their transport across cell membranes.

MT1XP1 has been shown to be involved in the regulation of a wide range of physiological processes, including cell signaling, inflammation, and stress resistance. Its function as a potential drug target or biomarker is due to its unique structure and the various ways in which it can interact with other proteins.

One of the key factors that makes MT1XP1 an attractive drug target is its location on the genome. MT1XP1 is located on chromosome 16, which is a gene that has been implicated in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This location makes it a promising target for drugs that can modulate its function and cause a wide range of physiological changes.

Another factor that makes MT1XP1 an attractive drug target is its structure. MT1XP1 is a transmembrane protein that consists of four conserved domains: an extracellular domain, a transmembrane domain, an intracellular domain, and a C-terminal region. The extracellular domain is involved in cell signaling, while the transmembrane domain is responsible for the regulation of metal ions and their transport across the membrane. The intracellular domain is involved in protein-protein interactions, and the C-terminal region is involved in stability and cytoplasmic localization.

MT1XP1's unique structure also makes it a potential drug target. The protein is composed of a single copy of the gene, which means that any changes made to the gene will be expressed in the cell. This makes it easier to identify the effects of drugs on MT1XP1's function and to determine if the drug is having the desired effect. Additionally, the fact that MT1XP1 is a single copy gene also makes it easier to target the protein and to modulate its function.

In addition to its unique structure and location on the genome, MT1XP1 is also a protein that is involved in the regulation of a wide range of physiological processes. For example, MT1XP1 has been shown to be involved in the regulation of cell signaling, stem cell proliferation, and inflammation. Additionally, MT1XP1 has been shown to play a role in stress resistance, DNA damage repair, and cell cycle regulation.

These properties make MT1XP1 an attractive drug target for diseases that are characterized by dysfunction in these areas. For example, MT1XP1 has been shown to be involved in the regulation of cancer cell growth and metastasis, which makes it a potential target for cancer treatments. Additionally , MT1XP1's involvement in stress response and DNA damage repair makes it a potential target for treatments for neurodegenerative diseases.

Another use of MT1XP1 as a drug target is its role in inflammation. MT1XP1 has been shown to play a role in the regulation of inflammation and immune potential response. For example, MT1XP1 has been shown to be involved in the regulation of T-cell responses. and has been shown to play a role in the regulation of inflammation in the gut.

In addition to its potential as a drug target, MT1XP1 is also a potential biomarker. Its unique structure and the various ways in which it can interact with other proteins make it an attractive candidate for use as a biomarker. For example, MT1XP1 has been shown to be involved in the regulation of cell signaling and can be used as a marker for diseases characterized by dysfunction in these areas. Additionally, MT1XP1's involvement in stress response and DNA damage repair makes it a potential candidate for use as a biomarker for

Protein Name: Metallothionein 1X Pseudogene 1

The "MT1XP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MT1XP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MT2A | MT3 | MT4 | MTA1 | MTA1-DT | MTA2 | MTA3 | MTAP | MTARC1 | MTARC2 | MTATP6P1 | MTATP8P1 | MTBP | MTCH1 | MTCH2 | MTCL1 | MTCO1P1 | MTCO1P12 | MTCO1P15 | MTCO2P33 | MTCO3P1 | MTCO3P12 | MTCP1 | MTDH | MTERF1 | MTERF2 | MTERF3 | MTERF4 | MTF1 | MTF2 | MTFMT | MTFP1 | MTFR1 | MTFR1L | MTFR2 | MTG1 | MTG2 | MTHFD1 | MTHFD1L | MTHFD2 | MTHFD2L | MTHFD2P7 | MTHFR | MTHFS | MTHFSD | MTIF2 | MTIF3 | MTLN | MTM1 | MTMR1 | MTMR10 | MTMR11 | MTMR12 | MTMR14 | MTMR2 | MTMR3 | MTMR4 | MTMR6 | MTMR7 | MTMR8 | MTMR9 | MTMR9LP | MTND1P11 | MTND1P23 | MTND1P3 | MTND1P33 | MTND2P21 | MTND2P28 | MTND4P10 | MTND4P12 | MTND4P17 | MTND4P22 | MTND4P24 | MTND4P28 | MTND4P29 | MTND5P10 | MTND5P16 | MTND5P19 | MTND5P20 | MTND5P31 | MTND5P8 | MTND6P14 | MTND6P4 | MTNR1A | MTNR1B | MTO1 | MTOR | mTOR complex 1 | mTOR complex 2 | MTPAP | MTPN | MTR | MTRES1 | MTREX | MTRF1 | MTRF1L | MTRF1LP2 | MTRFR | MTRNR2L1 | MTRNR2L10